Giovanna Tosato

Q: What Schools Are Affiliated With Giovanna Tosato

Giovanna Tosato is affiliated with the following schools: University of Milan, University of Oxford, Kanazawa University, University of Tokyo, University System of Maryland, University of Padua, Osaka University, Columbia University, University of Bologna, Seoul National University, Harvard University

Giovanna Tosato's AcademicInfluence.com Rankings

Giovanna Tosato

Philosophy

#7411

World Rank

#10624

Historical Rank

Logic

#4462

World Rank

#5759

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Giovanna Tosato's Degrees

Doctorate Medicine University of Padua
PhD Biomedical Sciences University of Milan

Why Is Giovanna Tosato Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Giovanna Tosato is an Italian–American physician-scientist and cancer researcher investigating the endothelium, angiogenesis, and the hematopoietic stem cell niche. She heads the molecular and cell biology section in the laboratory of cellular oncology at the National Cancer Institute in the United States. Tosato was a division director in the Center for Biologics Evaluation and Research from 1992 to 1999.

(See a Problem?)

Giovanna Tosato's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo (1995) (749)
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. (1985) (531)
IL-10 inhibits human T cell proliferation and IL-2 production. (1992) (503)
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. (1996) (488)
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. (2003) (454)
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. (1999) (441)
Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management (1993) (394)
Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. (1986) (384)
Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. (2006) (382)
Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. (2002) (372)
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth (1998) (318)
Human interleukin-10 can directly inhibit T-cell growth. (1993) (315)
Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. (1979) (306)
Activity of thalidomide in AIDS-related Kaposi's sarcoma. (2000) (286)
Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. (1999) (261)
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). (1988) (260)
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. (2010) (244)
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. (1996) (238)
Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo (1997) (238)
Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. (2001) (236)
Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. (1990) (224)
Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. (1981) (215)
G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. (2006) (215)
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells (1990) (209)
Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity (2004) (206)
Activation of naive and memory T cells by interleukin-15. (1996) (204)
Induction of interleukin-6 during human immunodeficiency virus infection. (1990) (200)
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. (1993) (185)
Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. (1984) (184)
Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. (1999) (183)
The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. (1997) (171)
Contribution of the CXC chemokines IP‐10 and Mig to the antitumor effects of IL‐12 (1998) (151)
Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. (1979) (148)
Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. (2004) (146)
Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. (1999) (144)
Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. (2004) (141)
Epstein-Barr virus infection and immunoregulation in man. (1985) (133)
Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. (2005) (131)
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. (2013) (125)
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. (2011) (123)
IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. (1993) (122)
Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. (1999) (122)
Interleukin-15 promotes angiogenesis in vivo. (1997) (122)
Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. (2012) (120)
Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. (1999) (116)
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. (2005) (116)
Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. (1997) (115)
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. (2012) (115)
Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12 (1999) (115)
The Epstein-Barr virus and the immune system. (1987) (113)
Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. (2004) (112)
Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). (1985) (111)
B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes. (1980) (110)
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). (2016) (109)
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. (2006) (108)
Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes. (1988) (108)
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. (2009) (105)
Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. (2005) (104)
Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. (2000) (104)
A Role for the Interferon‐Inducible Protein 10 in Inhibition of Angiogenesis by Interleukin‐12 (1996) (103)
Interleukin-6 production in posttransplant lymphoproliferative disease. (1993) (103)
Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. (2001) (102)
Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells (1983) (101)
EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. (2006) (100)
Relationship between immunoglobulin production and immortalization by Epstein Barr virus. (1985) (99)
Prostaglandin E2 promotes degranulation‐independent release of MCP‐1 from mast cells (2006) (97)
Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. (2012) (97)
Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. (1998) (96)
Generation of Epstein‐Barr Virus (EBV)–Immortalized B Cell Lines (1991) (95)
The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. (2009) (94)
Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. (1991) (91)
Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. (2006) (90)
HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. (2004) (87)
Palmitoylation Controls Recycling in Lysosomal Sorting and Trafficking (2008) (87)
The Role of Chemokines in Hodgkin's Disease (2000) (87)
Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. (1994) (85)
NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. (1993) (84)
Role of human cripto-1 in tumor angiogenesis. (2005) (83)
Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. (2001) (83)
Viral interleukin-10 in chronic active Epstein-Barr virus infection. (1997) (82)
A pilot study of cidofovir in patients with kaposi sarcoma. (2003) (81)
Semaphorin 6A regulates angiogenesis by modulating VEGF signaling. (2012) (75)
Infection of human endothelial cells with Epstein-Barr virus (1995) (75)
Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells. (2007) (73)
Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. (1999) (73)
Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. (1999) (73)
A Syndrome of Peripheral Blood T-Cell Infection With Epstein-Barr Virus (EBV) Followed by EBV–Positive T-Cell Lymphoma (1998) (72)
Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. (2001) (70)
Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor (2009) (68)
Selective inhibition of immunoregulatory cell functions by cyclosporin A. (1982) (67)
The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses. (2001) (66)
The apoptosis-associated gamma-ray response of BCL-X(L) depends on normal p53 function. (1996) (66)
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection (2020) (66)
Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells. (2008) (64)
MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1 (2012) (62)
Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function (2002) (62)
Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. (1988) (62)
Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. (2002) (62)
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. (2003) (61)
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12 (2000) (60)
Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and management (2005) (60)
T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. (1982) (58)
Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies. (2011) (58)
Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands (2013) (56)
Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. (2008) (56)
Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. (2008) (55)
Derivation of Endothelial Cells from CD34− Umbilical Cord Blood (2004) (55)
The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells (1988) (54)
Evidence for the involvement of SDF‐1 and CXCR4 in the disruption of endothelial cell‐branching morphogenesis and angiogenesis by TNF‐α and IFN‐γ (2004) (53)
Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells. (1997) (51)
The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. (2010) (49)
Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Primary Effusion Lymphomas (2001) (49)
MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. (1999) (49)
Macrophage-Derived Chemokine Expression in Classical Hodgkin's Lymphoma: Application of Tissue Microarrays (2001) (48)
B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines. (1985) (48)
A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. (1998) (47)
Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. (2000) (47)
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin (2002) (46)
Human and viral interleukin-10 in acute Epstein-Barr virus-induced infectious mononucleosis. (1995) (46)
Neoplastic conditions in the context of HIV-1 infection. (2004) (46)
EphrinB2 controls vessel pruning through STAT1-JNK3 signaling (2015) (45)
Gene Regulation and Functional Alterations Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORFK13/vFLIP in Endothelial Cells (2008) (45)
Contribution of viral and cellular cytokines to Kaposi's sarcoma‐associated herpesvirus pathogenesis (2008) (43)
Diagnosis of atypical cases of infectious mononucleosis. (2001) (43)
Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. (1994) (43)
Hla-matched platelet transfusion therapy of severe aplastic anemia. (1978) (41)
A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. (1994) (41)
Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage (1994) (41)
Target-induced death by apoptosis in human lymphokine-activated natural killer cells. (1996) (40)
Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling (2016) (39)
Serum inactivation contributes to the failure of stromal‐derived factor‐1 to block HIV‐I infection in vivo (2003) (39)
PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity (2011) (38)
Chronic persistent Epstein‐Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion (1996) (38)
B-cell-derived interleukin-1 (IL-1)-like factor. II. Sources, effects, and biochemical properties. (1985) (37)
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. (2000) (37)
Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. (1994) (37)
Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma (2009) (37)
Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression. (2014) (35)
HLA-matched platelet transfusion therapy of severe aplastic anemia. (1978) (34)
EBV-NK cells interactions and lymphoproliferative disorders. (1998) (33)
Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection. (1999) (32)
Pure red blood cell aplasia associated with chronic Epstein-Barr virus infection: evidence for T cell-mediated suppression of erythroid colony forming units. (1984) (32)
Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. (2007) (31)
Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6 (1992) (30)
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity. (2007) (30)
Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow. (2016) (30)
Pathogenesis and manifestations of human herpesvirus-8-associated disorders. (2003) (29)
Kadi4Mat: A Research Data Infrastructure for Materials Science (2021) (28)
Epstein-Barr virus as an agent of haematological disease. (1995) (28)
FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. (2007) (28)
Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. (2004) (28)
The role of lactic acid in autocrine B-cell growth stimulation. (1991) (28)
Interferon-mediated inhibition of human polyclonal immunoglobulin synthesis. (1982) (28)
Targeted inhibition of angiogenic factors in AIDS-related disorders. (2003) (27)
Interactions between HIV-1 Tat and KSHV. (2007) (27)
Adult human circulating CD34⁻Lin⁻CD45⁻CD133⁻ cells can differentiate into hematopoietic and endothelial cells. (2011) (27)
Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4 positive lymphocytes (1990) (26)
Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivo. (1998) (26)
Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques. (1993) (25)
Generation of Epstein‐Barr Virus (EBV)–Immortalized B Cell Lines (1991) (25)
Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis. (2007) (25)
Infectious mononucleosis as a disease of early childhood in Japan caused by primary Epstein‐Barr virus infection (1997) (24)
Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas. (2000) (24)
Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. (1987) (24)
Use of In Vitro Assays in Selection of Compatible Platelet Donors (1980) (24)
Cytosolic phospholipase A2{alpha} and cancer: a role in tumor angiogenesis. (2010) (23)
Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma. (1996) (22)
Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1 (2015) (21)
A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein (2013) (20)
Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus. (2009) (20)
Acute hæmorrhagic conjunctivitis during an epidemic outbreak of adenovirus-type-4 infection (1975) (20)
Antibodies to Epstein‐Barr virus‐associated nuclear antigen and to other viral and non‐vical antigens in Hodgkin's Disease (1975) (20)
Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells. (1995) (19)
Reversal of infectious mononucleosis-associated suppressor T cell activity by D-mannose (1983) (19)
Epstein-Barr virus immortalization of normal cells of B cell lineage with nonproductive, rearranged immunoglobulin genes. (1986) (19)
EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta (2016) (19)
Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD (2004) (18)
Interleukin‐18 expression induced by Epstein‐Barr virus‐infected cells (2001) (17)
Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6. (1992) (17)
Human herpesvirus 8+ polyclonal IgMλ B‐cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV‐infected patients (2013) (16)
Lymphatic regeneration: new insights from VEGFR-3 blockade. (2005) (15)
The Post-Infectious Chronic Fatigue Syndrome (1989) (14)
Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression. (2018) (14)
Tumor cell populations differ in angiogenic activity: a model system for spontaneous angiogenic switch can tell us why. (2006) (14)
Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies. (2005) (14)
Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors. (1985) (14)
Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. (1978) (14)
Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1 (2020) (13)
NF-κB Activation Stimulates Transcription and Replication of Retrovirus XMRV in Human B-Lineage and Prostate Carcinoma Cells (2011) (13)
Therapeutic options for human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus-related disorders (2004) (13)
Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration (2017) (13)
A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma (2019) (12)
Neuropilin-2: a new molecular target for antiangiogenic and antitumor strategies. (2008) (12)
Ephrin ligands and Eph receptors contribution to hematopoiesis (2017) (12)
Chemokine Gene Expression and Clonal Analysis of B Cells in Tissues Involved by Lymphoid Interstitial Pneumonitis from HIV-Infected Pediatric Patients (2001) (11)
Biochemical and biological analysis of human interleukin 6 expressed in rodent and primate cells. (1990) (10)
Targeting the tumor vasculature to improve the efficacy of oncolytic virus therapy. (2007) (10)
Contribution of Viral Mimics of Cellular Genes to KSHV Infection and Disease (2014) (10)
Contribution of automated hematology analysis to the detection of apoptosis in peripheral blood lymphocytes. (2000) (10)
DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis (2019) (10)
Canstatin: an inhibitor of angiogenesis and tumor growth revisited. (2006) (9)
Investigation of the interactions between the EphB2 receptor and SNEW peptide variants (2014) (9)
Development of EBV-positive T-cell lymphoma following infection of peripheral blood T cells with EBV. (1999) (9)
Large deletion of the X‐linked lymphoproliferative disease gene detected by fluorescence in situ hybridization (2000) (8)
Suppressor T-cell function in man: suppression of immunoglobulin production by the direct action of immunoregulatory T cells on the B cell in four separate, distinct systems. (1982) (8)
Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas (2017) (8)
Cellular distribution of a human I-A-like (DS/DC) antigen on normal and neoplastic lymphoid cells. (1985) (7)
Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma (2019) (7)
Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization. (2000) (7)
Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4 positive lymphocytes. (1990) (6)
Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth (2020) (6)
The role of cell surface lectin--carbohydrate interactions in cellular recognition, cooperation, and regulation. (1983) (6)
ADMINISTRATION OF INTERLEUKIN 12 (IL-12) TO PATIENTS (PTS) WITH AIDS-ASSOCIATED KAPOSI'S SARCOMA (KS): PRELIMINARY RESULTS OF A PILOT STUDY (1999) (5)
Interferon-α Is Implicated in the Transcriptional Regulation of Vascular Endothelial Growth Factor (2003) (5)
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6) (1988) (5)
Calreticulin and Tumor Suppression (2003) (4)
Interferon-inducible Protein 10 Is a Potent Inhibitor o f Angiogenesis In Vivo (2003) (4)
Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. (2010) (4)
Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships. (1993) (4)
Novel insights into endothelial cell malignancies (2018) (4)
Notch and TGFβ (2014) (3)
THE HUMAN INTERLEUKIN 2 RECEPTOR ,0 CHAIN (p70) (1988) (3)
A severe illness associated with EBV infection of T and NK cells (2001) (3)
Viral and cellular cytokines as therapeutic targets in AIDS-related lymphoproliferative disorders. (2003) (3)
A mechanism of T cell regulation of Epstein-Barr virus latency. (1993) (3)
A Monocyte‐derived B Cell Growth Factor Is IFN‐β2/BSF‐2/IL‐6 a (1989) (3)
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) (2010) (3)
Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy (2014) (3)
Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations (2011) (3)
A MONOCLONAL ANTIBODY DIRECTED AGAINST A HUMAN B LYMPHOID CELL ACTIVATION ANTIGEN (1982) (3)
A Merging of Disciplines (1989) (3)
Preliminary results of a phase II study of oral thalidomide in patients with AIDS-related Kaposl's sarcoma (KS) (1998) (3)
Lymphoid cell-derived lectin-like receptor molecules as immunoregulatory signals in immunodeficiency. (1983) (2)
Iterative epigenomic analyses in the same single cell (2020) (2)
Defective allosuppression in patients with ataxia-telangiectasia. (1985) (2)
Bone Marrow Amyloid in Patients with M-component (1977) (2)
GRANULOCYTE INFILTRATION AND EXPRESSION OF THE PRO-ANGIOGENIC BV8 PROTEIN IN EXPERIMENTAL EL4 AND LEWIS LUNG CARCINOMA TUMORS. (2013) (2)
Optical faraday-rotation studies of spin-lattice relaxation time in NdES (1969) (2)
Antisense transcription from lentiviral gene targeting linked to an integrated stress response in colorectal cancer cells (2022) (2)
Cell-Mediated Immunity (1989) (2)
Interferon-alpha is implicated in the transcriptional regulation of vascular endothelial growth factor. (2003) (2)
Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD). (2007) (1)
KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease (2010) (1)
Inactivation of axon guidance molecule netrin-1 in human colorectal cancer by an epigenetic mechanism. (2022) (1)
Epidemiological study of an "hand-foot-and-mouth disease" outbreak observed in Rome in the fall of 1973. (1975) (1)
Immune Assessment of Patients with Chronic Active EBV Infection (CAEBV) (1985) (1)
Bone marrow niches in myelodysplastic syndromes (2021) (1)
IAM-CMS/kadi: Kadi4Mat (2020) (1)
Ephrin ligands and Eph receptors contribution to hematopoiesis (2017) (1)
A monocyte-derived B cell growth factor is IFN-beta 2/BSF-2/IL-6. (1989) (1)
Monocytes and a Monocyte Product Regulate Epstein-Barr Virus-Induced B Cell Activation (1987) (0)
Abnormally elevated serum interleukin 6 levels in individuals with human immunodeficiency virus infection (1990) (0)
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD) (2009) (0)
Preliminary results of a clinical trial using chemo-immunotherapy in Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman’s disease (MCD) (2008) (0)
chemokine stromal-derived factor-1 Regulation of endothelial cell branching morphogenesis by endogenous (2013) (0)
Studies of Epstein-Barr Virus Infection and Immunoregulation in Patients with Aids and Aids-Related Disorders (1991) (0)
Introduction: Herpesviruses in hematology (2003) (0)
Abstract 3469: EphrinB2 promotes endothelial cell survival and vascular integrity (2011) (0)
Hand, foot and mouth disease (Coxsackie virus A 16): clinical findings in patients observed in Rome. (1974) (0)
Use of Rapamycin to inhibit VEGF for the treatment of primary effusion lymphoma (2008) (0)
Induction of Interleukin-6 During Human Immunodeficiency . G / ) Virus Infection 87 PP 7855 (0)
TNF-a + IFN-g suppress SDF-1 expression in endothelial cells (2004) (0)
interleukin-6 Regulation of B-cell growth and immunoglobulin gene transcription (2003) (0)
Reusable Single Cell for Iterative Epigenomic Analyses. (2022) (0)
Development of Opportunistic Non-Hodgkin’s Lymphomas in Severely Immunosuppressed HIV-Infected Patients Receiving Long-Term Antiretroviral Therapy (1992) (0)
Growth Stimulation and Immunoglobulin (Ig) Secretion in Epstein-Barr Virus (Ebv)-Infected B Cells by Interleukin 6 (IL-6) (1989) (0)
Identiﬁcation of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell–derived factor-1 (cid:1) in the circulation (2005) (0)
Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus (2009) (0)
Phase I/II study of the safety, pharmacokinetics, and efficacy of pomalidomide in the treatment of Kaposi sarcoma in individuals with or without HIV. (2013) (0)
Primary Effusion Lymphoma (2014) (0)
Endothelial Cells in ORFK 13 / vFLIP Herpesvirus-Encoded Induced by Kaposi ' s Sarcoma-Associated Gene Regulation and Functional Alterations (2009) (0)
The chemokines IP-10 and Mig identified as mediators of tumor necrosis in vivo (1997) (0)
148 Kaposiʼs Sarcoma-Associated Herpesvirus (KSHV)-Related Multicentric Castlemanʼs Disease (MCD) and Inflammatory Cytokine Syndrome (KICS): Pathogenesis and Treatment (2012) (0)
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses (2009) (0)
Hamiltonian Markov chains in light transport (2018) (0)
Characterization of porous membranes using artificial neural networks (2023) (0)
Bone marrow hemogenic endothelial cells contribute multilineage hematopoietic progenitors in adult mice (2022) (0)
#511 Interleukin-15 promotes angiogenesis in vivo (1997) (0)
PATHOPHYSIOLOGICAL ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR/VASCULAR PERMEABILITY FACTOR (VEGF/VPF) IN PRIMARY EFFUSION LYMPHOMAS (1999) (0)
independently of vascular endothelial growth factor receptor-2 Neuropilin-1 regulates attachment in human endothelial cells (2013) (0)
Measurement of Polyclonal Immunoglobulin Synthesis Using the Reverse Plaque Technique (1991) (0)
Science Signaling Podcast for 15 March 2016: An inflammatory peptide in blood vessels (2016) (0)
Requirement of ephrinB activation in mural cells association with endothelial cells during new vessel formation (2008) (0)
Rapid Publication (2003) (0)
Optimization of the Lead Compound NVP-BHG712 as Colorectal Cancer Inhibitor. (2023) (0)
Conflicting results from clinical observations and murine models: what is the role of plasminogen activators in tumor growth? (2006) (0)
Characterization of Semaphorin 6A-Mediated Effects on Angiogenesis Through Regulation of VEGF Signaling. (2017) (0)
Reversal of Common Variable Hypogammaglobulinemia-Associated Suppressor Cell Activity by Specific Carbohydrates (1985) (0)
at the 40th Annual American Society of Hematology Meeting, December 7, part Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 : Presented in Angiogenesis and Hematopoiesis Induced by Kaposi's (2013) (0)
Monocyte Contrasuppression of EBV-Immune Regulatory T Cells (1985) (0)
The role of ephrinB2 in hematopoietic stem/progenitor cell differentiation from an arterial hemogenic endothelium (2014) (0)

This paper list is powered by the following services:

Other Resources About Giovanna Tosato

en.wikipedia.org

What Schools Are Affiliated With Giovanna Tosato?

Giovanna Tosato is affiliated with the following schools:

Giovanna Tosato's Academic­Influence.com Rankings